Sophia Balderman is a Hematology physician affiliated with Cleveland Clinic. OpenAlex indexes 94 publications with 672 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
716-845-2300Provider last certified this registry record 17 Jan 2022.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
44.5%Antimetabolite10.4%Hydroxyurea100%Part D≥11 patientsKinase inhibitor8.8%Jakafi61%Sprycel39%Part D<11 patients+ 4 more classes in this area
Anti-infectives
20.8%Fluoroquinolone Antibacterial11.5%Levofloxacin100%Part D≥16 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.9%Valacyclovir100%Part D<11 patients+ 1 more class in this area
Dermatology
20.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor20.3%Acyclovir100%Part D≥28 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of <i>TP53</i> mutation on survival outcomes in acute lymphoblastic leukemia at a tertiary center
Leukemia & lymphoma/Leukemia and lymphoma
2025 - Impact of Cytogenetic Response to Therapy on Long‐Term Survival in Acute Myeloid Leukemia
American Journal of Hematology
2025 - Clonal hematopoiesis in patients with non-hematologic cancers: Prevalence and detectability in primary tumor tissue.
Journal of Clinical Oncology
2025 - Comparing Outcomes of First-Line Intensive Chemotherapeutic Regimens in Adult Patients With Acute Lymphoblastic Leukemia at a Tertiary Center
Clinical Lymphoma Myeloma & Leukemia
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”